Abstract
Rosacea is a chronic inflammatory skin disorder, which seems to have a neurovascular component. Flushing in rosacea has been reported to be associated with a neuropathic burning or stinging pain, and the release of a number of neuropeptides. Associated neuropeptides include vasoactive intestinal peptide, and pituitary adenylate cyclase activating peptide, which both promote neurogenic inflammation and have been related to neurological disorders, namely, migraine. An association between rosacea and several neurological conditions has been suggested, including Alzheimer’s disease, glioma, migraine, and Parkinson’s disease. This chapter critically discusses the presence of neurological comorbidities in rosacea, including possible pathophysiological mechanisms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Piccolo V, Russo T, Bove D, Baroni A. Segmental immune disorders resulting from neurologic injuries. Clin Dermatol. 2014;32(5):628–32.
Vissing SF, Hjortsø EM. Central motor command activates sympathetic outflow to the cutaneous circulation in humans. J Physiol. 1996;492(3):931–9.
Seeliger S, Buddenkotte J, Schmidt-Choudhury A, Rosignoli C, Shpacovitch V, Von Arnim U, et al. Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo. Am J Pathol. 2010;177(5):2563–75.
Grant AD, Gerard NP, Brain SD. Evidence of a role for NK1and CGRP receptors in mediating neurogenic vasodilatation in the mouse ear. Br J Pharmacol. 2002;135(2):356–62.
Starr A, Graepel R, Keeble J, Schmidhuber S, Clark N, Grant A, et al. A reactive oxygen species-mediated component in neurogenic vasodilatation. Cardiovasc Res. 2008;78(1):139–47.
Pozsgai G, Bodkin JV, Graepel R, Bevan S, Andersson DA, Brain SD. Evidence for the pathophysiological relevance of TRPA1 receptors in the cardiovascular system in vivo. Cardiovasc Res. 2010;87(4):760–8.
Drott C, Claes G, Rex L. Facial blushing treated by sympathetic denervation -- longlasting benefits in 831 patients. J Cosmet Dermatol. 2002;1(2):115–9.
Schram A, James W. Neurogenic rosacea treated with endoscopic thoracic sympathectomy. Arch Dermatol. 2012;148(2):270–1.
Seiffert K, Ding W, Wagner JA, Granstein RD. ATPγS enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling. J Invest Dermatol. 2006;126(5):1017–27.
Christensen CE, Andersen FS, Wienholtz N, Egeberg A, Thyssen JP, Ashina M. The relationship between migraine and rosacea: systematic review and meta-analysis. Cephalalgia. 2017;38:1387.
Tan SG, Cunliffe WJ. Rosacea and migraine. Br Med J. 1976;1(6000):21.
Berg M, Lidén S. An epidemiological study of rosacea. Acta Derm Venereol. 1989;69(5):419–23.
Egeberg A, Ashina M, Gaist D, Gislason GH, Thyssen JP. Prevalence and risk of migraine in patients with rosacea: a population-based cohort study. J Am Acad Dermatol. 2017;76(3):1–5.
Wienholtz N, Christensen CE, Egeberg A, Thyssen JP, Ashina M. Vasomotor reactions in the face and head of patients with migraine. Cephalalgia Rep [Internet]. 2018;1:251581631879054; available from: http://journals.sagepub.com/doi/10.1177/2515816318790543.
Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Patients with rosacea have increased risk of dementia. Ann Neurol. 2016;79(6):921–8.
Alexoudi A, Alexoudi I, Gatzonis S. Parkinson’s disease pathogenesis, evolution and alternative pathways: a review. Rev Neurol [Internet]. 2018;174:699. s0035-3787(17):30683–5. Available from: https://doi.org/10.1016/j.neurol.2017.12.003.
Fischer M, Gemende I, Marsch W, Fischer P. Skin function and skin disorders in Parkinson’s disease. J Neural Trasm. 2001;108(2):205–13.
Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Exploring the association between rosacea and Parkinson disease. JAMA Neurol. 2016;73(5):529.
Mathieu RJ, Guido N, Ibler E, Serrano L, Rangel SM, Schlosser BJ, et al. Rosacea and subsequent diagnosis for Parkinson’s disease: a large, urban, single center, US patient population retrospective study. J Eur Acad Dermatol Venereol. 2017;32(4):141–4.
Chung YC, Kim YS, Bok E, Yune TY, Maeng S, Jin BK. MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson’s disease. Mediat Inflamm. 2013;2013:370526.
Alexoudi A, Alexoudi I, Gatzonis S. Association between rosacea and Parkinson disease. JAMA Neurol. 2016;73(9):1159.
Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Association of rosacea with risk for glioma in a Danish nationwide cohort study. JAMA Dermatol. 2016;152(5):541–5.
Long J, Li J, Yuan X, Tang Y, Deng Z, Xu S, et al. Potential association between rosacea and cancer: a study in a medical center in southern China. J Dermatol. 2019;46:570.
Rizzi M, Penner F, Messina G, Castelli N, Franzini A, Capella GL. Painful rosacea as a warning sign of intracranial metastasis of squamous cell carcinoma. Headache. 2016;56(9):1514–6.
Goertzen C, Mahdi H, Laliberte C, Meirson T, Gil-henn H, Magalhaes M. Oral inflammation promotes oral squamous cell carcinoma invasion. Oncotarget. 2018;9(49):29047–63.
Kähäri VM, Saarialho-Kere U. Matrix metalloproteinases in skin. Exp Dermatol. 1997;6(5):199–213.
Yan W, Zhang W, Sun L, Liu Y, You G, Wang Y, et al. Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme. Brain Res. 2011;1411:108–15.
Musumeci G, Magro G, Cardile V, Coco M, Marzagalli R, Castrogiovanni P, et al. Characterization of matrix metalloproteinase-2 and -9, ADAM-10 and N-cadherin expression in human glioblastoma multiforme. Cell Tissue Res. 2015;362(1):45–60.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Wienholtz, N.K.F., Thyssen, J.P., Egeberg, A. (2020). Rosacea and Neurological Comorbidities. In: Cary, J.H., Maibach, H.I. (eds) Rosacea. Updates in Clinical Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-52097-7_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-52097-7_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-52096-0
Online ISBN: 978-3-030-52097-7
eBook Packages: MedicineMedicine (R0)